Differential effects of p-chloromercuriphenyl sulfonate on arterial responses to epinephrine and serotonin.
D002731:4-Chloromercuribenzenesulfonate / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000818:Animals; D001158:Arteries; D003545:Cysteine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D005260:Female; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects*; D009130:Muscle, Smooth / Q000187:drug effects; D010646:Phentolamine / Q000494:pharmacology; D010663:Phenylmercury Compounds / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000494:pharmacology; D012702:Serotonin Antagonists; D013997:Time Factors; D014666:Vasomotor System / Q000187:drug effects*
D010663:Phenylmercury Compounds; D012702:Serotonin Antagonists; D012701:Serotonin; D002731:4-Chloromercuribenzenesulfonate; D003545:Cysteine; D007545:Isoproterenol; D004837:Epinephrine; D010646:Phentolamine